Terms: = Endocrine gland cancer AND HRAS, K-ras, 3265, ENSG00000174775, HRAS1, RASH1, c-bas/has, P01112, N-ras AND Staging
20 results:
1. Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer.
Semsar-Kazerooni K; Morand GB; Payne AE; da Silva SD; Forest VI; Hier MP; Pusztaszeri MP; Tamilia M; Payne RJ
J Otolaryngol Head Neck Surg; 2022 Mar; 51(1):9. PubMed ID: 35246262
[TBL] [Abstract] [Full Text] [Related]
2. BRAF
Bakkar S; Macerola E; Aljarrah Q; Proietti A; Materazzi G; Basolo F; Miccoli P
Updates Surg; 2019 Dec; 71(4):701-704. PubMed ID: 31586312
[TBL] [Abstract] [Full Text] [Related]
3. Molecular Variants and Their Risks for Malignancy in Cytologically Indeterminate Thyroid Nodules.
Goldner WS; Angell TE; McAdoo SL; Babiarz J; Sadow PM; Nabhan FA; Nasr C; Kloos RT
Thyroid; 2019 Nov; 29(11):1594-1605. PubMed ID: 31469053
[No Abstract] [Full Text] [Related]
4. Applications of endoscopic ultrasound in pancreatic cancer.
Luz LP; Al-Haddad MA; Sey MS; DeWitt JM
World J Gastroenterol; 2014 Jun; 20(24):7808-18. PubMed ID: 24976719
[TBL] [Abstract] [Full Text] [Related]
5. Trismus and diffuse polymyalgia: an unusual presentation of recurrent metastatic ovarian cancer.
Benjamin R; Zhai J; Morgan R; Prakash N
BMJ Case Rep; 2014 May; 2014():. PubMed ID: 24835804
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic value of k-ras mutation status and subtypes in endoscopic ultrasound-guided fine-needle aspiration specimens from patients with unresectable pancreatic cancer.
Ogura T; Yamao K; Hara K; Mizuno N; Hijioka S; Imaoka H; Sawaki A; Niwa Y; Tajika M; Kondo S; Tanaka T; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
J Gastroenterol; 2013 May; 48(5):640-6. PubMed ID: 22983505
[TBL] [Abstract] [Full Text] [Related]
7. k-ras mutational status predicts poor prognosis in unresectable pancreatic cancer.
Chen H; Tu H; Meng ZQ; Chen Z; Wang P; Liu LM
Eur J Surg Oncol; 2010 Jul; 36(7):657-62. PubMed ID: 20542658
[TBL] [Abstract] [Full Text] [Related]
8. Aneuploidy and high S-phase as biomarkers of poor clinical outcome in poorly differentiated and anaplastic thyroid carcinoma.
Pinto AE; Silva G; Banito A; Leite V; Soares J
Oncol Rep; 2008 Oct; 20(4):913-9. PubMed ID: 18813835
[TBL] [Abstract] [Full Text] [Related]
9. [Pancreatic cancer].
Schmid RM
Praxis (Bern 1994); 2006 Nov; 95(44):1709-12. PubMed ID: 17111879
[TBL] [Abstract] [Full Text] [Related]
10. Unfavourable prognosis associated with k-ras gene mutation in pancreatic cancer surgical margins.
Kim J; Reber HA; Dry SM; Elashoff D; Chen SL; Umetani N; Kitago M; Hines OJ; Kazanjian KK; Hiramatsu S; Bilchik AJ; Yong S; Shoup M; Hoon DS
Gut; 2006 Nov; 55(11):1598-605. PubMed ID: 16682430
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic implications of routine, immunohistochemical, and molecular staging in resectable pancreatic adenocarcinoma.
Niedergethmann M; Rexin M; Hildenbrand R; Knob S; Sturm JW; Richter A; Post S
Am J Surg Pathol; 2002 Dec; 26(12):1578-87. PubMed ID: 12459624
[TBL] [Abstract] [Full Text] [Related]
12. Copy number of cancer genes predict tumor grade and survival of pancreatic cancer patients.
Nagy A; Kozma L; Kiss I; Ember I; Takacs I; Hajdu J; Farid NR
Anticancer Res; 2001; 21(2B):1321-5. PubMed ID: 11396207
[TBL] [Abstract] [Full Text] [Related]
13. Colloid (mucinous noncystic) carcinoma of the pancreas.
Adsay NV; Pierson C; Sarkar F; Abrams J; Weaver D; Conlon KC; Brennan MF; Klimstra DS
Am J Surg Pathol; 2001 Jan; 25(1):26-42. PubMed ID: 11145249
[TBL] [Abstract] [Full Text] [Related]
14. k-ras point mutation in the nerve plexuses around the superior mesenteric artery in resectable adenocarcinoma of the pancreatic head: distribution pattern and related factors.
Ohigashi H; Ishikawa O; Sasaki Y; Yamada T; Furukawa H; Imaoka S; Kasugai T; Ishiguro S; Ueda K; Miyoshi Y; Nakamura Y
Arch Surg; 2000 Dec; 135(12):1450-5. PubMed ID: 11115351
[TBL] [Abstract] [Full Text] [Related]
15. Outcome of pancreatic cancer patients based on genetic lymph node staging.
Yamada T; Nakamori S; Ohzato H; Higaki N; Aoki T; Oshima S; Shiozaki K; Okami J; Hayashi N; Nagano H; Dono K; Umeshita K; Sakon M; Monden M
Int J Oncol; 2000 Jun; 16(6):1165-71. PubMed ID: 10811991
[TBL] [Abstract] [Full Text] [Related]
16. [Endoscopy in the diagnosis and staging of pancreatic cancer].
Spinelli P; Schiavo M; Schicchi AA
Tumori; 1999; 85(1 Suppl 1):S14-8. PubMed ID: 10235074
[TBL] [Abstract] [Full Text] [Related]
17. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract] [Full Text] [Related]
18. The incidence of port-site metastases might be reduced.
Reymond MA; Wittekind C; Jung A; Hohenberger W; Kirchner T; Köckerling F
Surg Endosc; 1997 Sep; 11(9):902-6. PubMed ID: 9294269
[TBL] [Abstract] [Full Text] [Related]
19. Thyroid carcinoma.
Gillenwater AM; Weber RS
Cancer Treat Res; 1997; 90():149-69. PubMed ID: 9367082
[TBL] [Abstract] [Full Text] [Related]
20. [Immunohistological study on ras and myc oncogene products in pancreatic cancer].
Motoshima K; Kohara N; Shiogama T; Fujii M; Nakago S; Tsunoda T; Nagata Y
Nihon Geka Gakkai Zasshi; 1990 Jan; 91(1):123-9. PubMed ID: 2138243
[TBL] [Abstract] [Full Text] [Related]
